NPPB and heart failure: Although BNP and NT-proBNP have been widely used in patients with heart failure, their use in HD patients is challenging because of high individual variations, increased plasma levels without any evidence of cardiac disease, more than normal values in 90% of HD patients, and wide differences in cutoff value for risk stratification in diverse studies (29–31).